Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Luminex's xTag Respiratory Viral Panel Fast Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday that the US Food and Drug Administration has given 510(k) clearance for its xTag Respiratory Viral Panel Fast.

The panel includes respiratory syncytial virus; influenza A; non-specific influenza A; H1 subtype; H3 subtype; influenza B; metapneumovirus; adenovirus; and entero-rhinovirus.

The availability of the test, Luminex said, will provide diagnostic laboratories testing options for a frontline assay that targets eight essential respiratory pathogens and delivers up to 96 patient results in a few hours.

The xTag RVP Fast panel runs on Luminex's 100/200 platform and will be commercially available from Abbott Molecular Diagnostics and Fisher Healthcare, Luminex's distribution partners.

Other molecular diagnostics from Luminex for infectious disease include the xTag RVP for respiratory viral panel testing of 12 viruses such as H1N1; the xTag Gastrointestinal Pathogen Panel; and the MultiCode-RTx Herpes Simplex Virus 1&2, the first FDA-approved PCR-based qualitative test for detecting and typing HSV-1 and HSV-2.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.